PMED — Peptonic Medical AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK10.37m
- SEK14.54m
- SEK14.79m
Annual cashflow statement for Peptonic Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | SAS | SAS | SAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -73.7 | -36.9 | -42.6 | -60 | -22.2 |
| Non-Cash Items | 26.8 | 4.65 | 7.05 | 1.9 | 4.43 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.51 | -8.01 | 1.73 | 21.8 | -0.371 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -40.3 | -40.2 | -33.8 | -36.4 | -18.2 |
| Capital Expenditures | -4.28 | -0.987 | -1.93 | -1.2 | -0.162 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.476 | 0 | -17.1 | -5.99 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.8 | -0.987 | -19.1 | -7.19 | -0.162 |
| Financing Cash Flow Items | -0.015 | -3.44 | -13.7 | -9.8 | -3.18 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15 | 34.6 | 64.4 | 31.4 | 16.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -29.2 | -6.59 | 11.6 | -11.4 | -2.83 |